BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18077641)

  • 1. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
    Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
    J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
    Li J; Shan Y; Fan S; Liu X
    Mycopathologia; 2014 Oct; 178(3-4):279-83. PubMed ID: 25118875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA.
    Mirhendi H; Bruun B; Schønheyder HC; Christensen JJ; Fuursted K; Gahrn-Hansen B; Johansen HK; Nielsen L; Knudsen JD; Arendrup MC
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1409-16. PubMed ID: 21607825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
    Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
    Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
    Asadzadeh M; Alanazi AF; Ahmad S; Al-Sweih N; Khan Z
    PLoS One; 2019; 14(10):e0223920. PubMed ID: 31618264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida nivariensis in comparison to different phenotypes of Candida glabrata.
    Swoboda-Kopeć E; Sikora M; Golas M; Piskorska K; Gozdowski D; Netsvyetayeva I
    Mycoses; 2014 Dec; 57(12):747-53. PubMed ID: 25267284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida bracarensis bloodstream infection in an immunocompromised patient.
    Warren TA; McTaggart L; Richardson SE; Zhang SX
    J Clin Microbiol; 2010 Dec; 48(12):4677-9. PubMed ID: 20881164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a multiplex PCR for the rapid identification of Candida glabrata species complex in Mexican clinical isolates.
    Reyes-Montes MDR; Acosta-Altamirano G; Duarte-Escalante E; Salazar EG; Martínez-Herrera E; Arenas R; González G; Frías-De-León MG
    Rev Inst Med Trop Sao Paulo; 2019 Aug; 61():e37. PubMed ID: 31411267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.
    Cuenca-Estrella M; Gomez-Lopez A; Isla G; Rodriguez D; Almirante B; Pahissa A; Rodriguez-Tudela JL;
    Med Mycol; 2011 Jul; 49(5):525-9. PubMed ID: 21198347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking for Candida nivariensis and C. bracarensis among a large Italian collection of C. glabrata isolates: results of the FIMUA working group.
    Esposto MC; Prigitano A; Romeo O; Criseo G; Trovato L; Tullio V; Fadda ME; Tortorano AM;
    Mycoses; 2013 May; 56(3):394-6. PubMed ID: 23170902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.
    Lockhart SR; Messer SA; Gherna M; Bishop JA; Merz WG; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2009 Apr; 47(4):1216-7. PubMed ID: 19193845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
    Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
    J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.
    Małek M; Mrowiec P; Klesiewicz K; Skiba-Kurek I; Szczepański A; Białecka J; Żak I; Bogusz B; Kędzierska J; Budak A; Karczewska E
    Folia Microbiol (Praha); 2019 May; 64(3):307-312. PubMed ID: 30361876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.
    Ellepola AN; Hurst SF; Elie CM; Morrison CJ
    Oral Microbiol Immunol; 2003 Dec; 18(6):379-88. PubMed ID: 14622344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
    Sharma C; Wankhede S; Muralidhar S; Prakash A; Singh PK; Kathuria S; Kumar DA; Khan N; Randhawa HS; Meis JF; Chowdhary A
    Diagn Microbiol Infect Dis; 2013 May; 76(1):46-50. PubMed ID: 23537782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new species, Candida subhashii, as a cause of peritonitis.
    Adam H; Groenewald M; Mohan S; Richardson S; Bunn U; Gibas CF; Poutanen S; Sigler L
    Med Mycol; 2009 May; 47(3):305-11. PubMed ID: 18798116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes.
    Ruan SY; Kuo YW; Huang CT; Hsiue HC; Hsueh PR
    Int J Antimicrob Agents; 2010 Jan; 35(1):85-8. PubMed ID: 19786341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
    Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
    J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR.
    Enache-Angoulvant A; Guitard J; Grenouillet F; Martin T; Durrens P; Fairhead C; Hennequin C
    J Clin Microbiol; 2011 Sep; 49(9):3375-9. PubMed ID: 21752976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.